RNA-based therapies: A cog in the wheel of lung cancer defense

Lung cancer (LC) is a heterogeneous disease consisting mainly of two subtypes, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), and remains the leading cause of death worldwide. Despite recent advances in therapies, the overall 5-year survival rate of LC remains less than 20%. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Parvez, Siddiqui, Jawed Akhtar, Lakshmanan, Imayavaramban, Ganti, Apar Kishor, Salgia, Ravi, Jain, Maneesh, Batra, Surinder Kumar, Nasser, Mohd Wasim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977189/
https://www.ncbi.nlm.nih.gov/pubmed/33740988
http://dx.doi.org/10.1186/s12943-021-01338-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977189/
https://www.ncbi.nlm.nih.gov/pubmed/33740988
http://dx.doi.org/10.1186/s12943-021-01338-2

Ejemplares similares